E-DRUG: A Medicine Pricing Analysis from Malaysia
----------------------------------------------
Dear E-druggers
Below please find the abstract of our article 'A Pricing Analysis of Cardiovascular & Blood Products After Privatization of Drug Distribution System in Malaysia' recently published by Journal of Pharmaceutical Finance, Economics & Policy Vol 14.3.
Here is the URL:
https://www.haworthpress.com/store/ArticleAbstract.asp?sid=FK4MFF84GMP68HUKDBH1UTPC2AABCT01&ID=64646
[Pls remember to 'repair' link]
Any one interested in full text, kindly let me know and I will be glad to send a copy.
Abstract
A Pricing Analysis of Cardiovascular and Blood Products After Privatization of Drug Distribution System in Malaysia
Zaheer ud Din Babar
Mohamed Izham Mohamed Ibrahim
Nadeem Irfan Bukhari
This study reviews privatization effect of Malaysian drug distribution system on prices of cardiovascular and blood products. After privatization prices show variable pattern, increased to (5%) after a year of privatization, decreased to 0.098% in 1997-2000 and again increased to 80% in year 2001-2003. The increase in prices after privatization could not be correlated with inflation rate and was not explained by any pricing mechanism. Comparison with International Reference Prices showed tremendously higher prices for most of the drugs. The findings invite enacting of price control mechanisms and adapting a reference and differential medicine pricing system to curb public expenditures.
KEYWORDS. Drug prices, privatization, cardiovascular, blood products, international reference prices
Regards,
Zaheer
Zaheer-Ud-Din-Babar
Malaysia
horizon_pharm@yahoo.com